126 related articles for article (PubMed ID: 25973316)
1. Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma.
Liu Z; Liu X; Cao W; Hua ZC
Am J Cancer Res; 2015; 5(2):792-801. PubMed ID: 25973316
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.
Yang YW; Zhang CM; Huang XJ; Zhang XX; Zhang LK; Li JH; Hua ZC
Sci Rep; 2016 Oct; 6():34178. PubMed ID: 27767039
[TBL] [Abstract][Full Text] [Related]
3. Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
Chen J; Wei D; Zhuang H; Qiao Y; Tang B; Zhang X; Wei J; Fang S; Chen G; Du P; Huang X; Jiang W; Hu Q; Hua ZC
Mol Cell Proteomics; 2011 Jun; 10(6):M111.009399. PubMed ID: 21474796
[TBL] [Abstract][Full Text] [Related]
4. Bacteria-mediated tumor-targeted delivery of tumstatin (54-132) significantly suppresses tumor growth in mouse model by inhibiting angiogenesis and promoting apoptosis.
Bao F; Liu M; Gai W; Hua Y; Li J; Han C; Zai Z; Li J; Hua Z
Front Med; 2022 Dec; 16(6):873-882. PubMed ID: 36152127
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific delivery of histidine-rich glycoprotein suppresses tumor growth and metastasis by anti-angiogenesis and vessel normalization.
Cheng X; Zhang X; Cheng W; Chen J; Ma C; Yang B; Hua ZC
Curr Gene Ther; 2014; 14(2):75-85. PubMed ID: 24606115
[TBL] [Abstract][Full Text] [Related]
6. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.
Chen J; Yang B; Cheng X; Qiao Y; Tang B; Chen G; Wei J; Liu X; Cheng W; Du P; Huang X; Jiang W; Hu Q; Hu Y; Li J; Hua ZC
Cancer Sci; 2012 Feb; 103(2):325-33. PubMed ID: 22054098
[TBL] [Abstract][Full Text] [Related]
7. Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer.
Zhang Q; Shim K; Wright K; Jurkevich A; Khare S
Mol Carcinog; 2016 Sep; 55(9):1355-68. PubMed ID: 26293890
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Effect of Cycle Inhibiting Factor Expression in Colon Cancer
Liu L; Zhang J; Gu M; Li G; Ni J; Fan M
Anticancer Agents Med Chem; 2020; 20(14):1722-1727. PubMed ID: 32324525
[TBL] [Abstract][Full Text] [Related]
9. Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines.
Moghaddam SM; Amini A; Wei AQ; Pourgholami MH; Morris DL
J Oncol; 2012; 2012():373826. PubMed ID: 23251157
[TBL] [Abstract][Full Text] [Related]
10. Infection of tumor cells with
Horiuchi Y; Nakamura A; Imai T; Murakami T
PNAS Nexus; 2024 Jan; 3(1):pgad484. PubMed ID: 38213616
[TBL] [Abstract][Full Text] [Related]
11. A Salmonella Typhimurium mutant strain capable of RNAi delivery: higher tumor-targeting and lower toxicity.
Cheng X; Zhang X; Zhou Y; Zhang C; Hua ZC
Cancer Biol Ther; 2014 Aug; 15(8):1068-76. PubMed ID: 24842165
[TBL] [Abstract][Full Text] [Related]
12. EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.
Cidre-Aranaz F; Grünewald TG; Surdez D; García-García L; Carlos Lázaro J; Kirchner T; González-González L; Sastre A; García-Miguel P; López-Pérez SE; Monzón S; Delattre O; Alonso J
Oncogene; 2017 Feb; 36(6):766-776. PubMed ID: 27375017
[TBL] [Abstract][Full Text] [Related]
13. Sprouty 1 predicts prognosis in human epithelial ovarian cancer.
Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
Am J Cancer Res; 2015; 5(4):1531-41. PubMed ID: 26101716
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.
Nadeau RJ; Toher JL; Yang X; Kovalenko D; Friesel R
J Cell Biochem; 2007 Jan; 100(1):151-60. PubMed ID: 16888801
[TBL] [Abstract][Full Text] [Related]
15. Sprouty2 regulates endochondral bone formation by modulation of RTK and BMP signaling.
Joo A; Long R; Cheng Z; Alexander C; Chang W; Klein OD
Bone; 2016 Jul; 88():170-179. PubMed ID: 27130872
[TBL] [Abstract][Full Text] [Related]
16. Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy.
Chen W; Wang Y; Qin M; Zhang X; Zhang Z; Sun X; Gu Z
ACS Nano; 2018 Jun; 12(6):5995-6005. PubMed ID: 29786420
[TBL] [Abstract][Full Text] [Related]
17. Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition.
Zhang Q; Wei T; Shim K; Wright K; Xu K; Palka-Hamblin HL; Jurkevich A; Khare S
Oncogene; 2016 Jun; 35(24):3151-62. PubMed ID: 26434583
[TBL] [Abstract][Full Text] [Related]
18. Cooperative and independent functions of FGF and Wnt signaling during early inner ear development.
Wright KD; Mahoney Rogers AA; Zhang J; Shim K
BMC Dev Biol; 2015 Oct; 15():33. PubMed ID: 26443994
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-mediated tumor-targeted delivery of engineered
Wu L; Li L; Li S; Liu L; Xin W; Li C; Yin X; Xu X; Bao F; Hua Z
Acta Pharm Sin B; 2022 Oct; 12(10):3952-3971. PubMed ID: 36213533
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
Gao X; Hicks KC; Neumann P; Patel TB
PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
